Form 13-F position report

VOR BIOPHARMA INC

Reported by Sarissa Capital Management LP

VOR CUSIP 929033207 Manager CIK 0001577524

Reported 25,399 shares, unchanged from the prior quarter.

Reported value 3.6%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 0.32% This manager · Q3 2026
Shares 25,399 Quarter-end amount reported
Reported value $484,613 Fair value at quarter end
Consecutive quarters held 5 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2025-09-30 1237439
2025-12-31 332219
2026-03-31 453118
2026-06-30 467596
2026-09-30 484613

Quarterly position history

How this manager's reported quarter-end position changed over time.

5 quarters
Quarterly reported position history for VOR BIOPHARMA INC held by Sarissa Capital Management LP.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 25,399 0 (0.0%) 0.32% $484,613 2026-11-16
Q2 2026 Unchanged 25,399 0 (0.0%) 0.26% $467,596 2026-08-14
Q1 2026 Unchanged 25,399 0 (0.0%) 0.29% $453,118 2026-05-15
Q4 2025 Unchanged 25,399 0 (0.0%) 0.15% $332,219 2026-02-17
Q3 2025 New 25,399 +25,399 (0.0%) 0.69% $1,237,439 2025-11-14

Who else reported the position

168 managers reported VOR BIOPHARMA INC for Q3 2026.

Managers reporting VOR BIOPHARMA INC in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
FMR LLC Added 6,759,007 +1,826,858 < 0.01% $128,961,854 5 qtrs
TCG Crossover Management LLC Unchanged 5,673,078 0 3.06% $108,242,328 3 qtrs
RA CAPITAL MANAGEMENT L P Added 4,503,882 +2,101,787 0.86% $85,934,069 5 qtrs
FCPM III SERVICES B V Reduced 3,405,279 -712,075 6.13% $64,972,723 5 qtrs
BlackRock Inc Reduced 3,306,494 -161,613 < 0.01% $63,087,906 5 qtrs
VR Adviser LLC Unchanged 3,041,719 0 2.82% $58,035,999 5 qtrs
Frazier Life Sciences Management L P Added 2,743,939 +200,000 1.3% $52,354,356 4 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Reduced 2,035,477 -48,851 < 0.01% $38,836,901 3 qtrs
STATE STREET CORPORATION Reduced 1,969,801 -646,535 < 0.01% $37,583,803 5 qtrs
Caligan Partners LP Unchanged 1,925,066 0 2.25% $36,730,259 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM NEW

Voting authority reported

Sole
25,399
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.